Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Hold” by Brokerages

Phreesia, Inc. (NYSE:PHR) has received a consensus rating of “Hold” from the nineteen analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $16.6471.

Several equities analysts recently issued reports on PHR shares. Piper Sandler cut Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price target on the stock. in a report on Thursday, May 28th. Robert W. Baird reiterated a “neutral” rating and issued a $10.00 price target (down from $25.00) on shares of Phreesia in a report on Tuesday, March 31st. Needham & Company LLC decreased their price target on Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, March 31st. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $16.00 price target (down from $24.00) on shares of Phreesia in a report on Tuesday, March 31st. Finally, Canaccord Genuity Group decreased their price target on Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, May 28th.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia shareholders backed leadership and governance matters at the company’s annual meeting, a sign of continued stockholder support for management. Phreesia Shareholders Back Leadership, Governance at Annual Meeting
• Neutral Sentiment: The company is receiving repeated reminders about a July 13, 2026 lead-plaintiff deadline in an investor lawsuit tied to stock purchases made between May 8, 2025 and March 30, 2026. These notices may keep Phreesia in the news, but they mostly reflect legal process rather than new operating results. Phreesia Deadline: PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
• Neutral Sentiment: Multiple law firms have announced or promoted the same class action lawsuit, suggesting the legal overhang is the main catalyst behind recent investor attention in PHR. Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
• Negative Sentiment: The securities fraud lawsuit and related deadline reminders can weigh on sentiment because they raise questions about past disclosures and may create headline risk for the stock. Phreesia, Inc. Class Action Reminder – Robbins LLP Encourages PHR Investors to Contact the Firm for Information About Their Rights

Insider Activity at Phreesia

In related news, insider David Linetsky sold 8,332 shares of the firm’s stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $8.07, for a total value of $67,239.24. Following the transaction, the insider owned 224,056 shares in the company, valued at $1,808,131.92. This trade represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Allison C. Hoffman sold 14,483 shares of the firm’s stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $8.07, for a total value of $116,877.81. Following the completion of the transaction, the general counsel owned 163,485 shares in the company, valued at approximately $1,319,323.95. This represents a 8.14% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 40,381 shares of company stock worth $343,758 over the last 90 days. Insiders own 5.20% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. Royal Bank of Canada boosted its holdings in Phreesia by 208.8% during the first quarter. Royal Bank of Canada now owns 24,119 shares of the company’s stock worth $617,000 after buying an additional 16,309 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Phreesia by 471.2% during the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company’s stock worth $4,090,000 after buying an additional 132,015 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Phreesia by 3.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company’s stock worth $1,599,000 after buying an additional 2,158 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in Phreesia by 262.7% during the first quarter. NewEdge Advisors LLC now owns 15,437 shares of the company’s stock worth $395,000 after buying an additional 11,181 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its holdings in Phreesia by 0.4% during the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company’s stock worth $15,336,000 after buying an additional 2,402 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Price Performance

Phreesia stock opened at $9.56 on Thursday. The business’s 50-day simple moving average is $9.32 and its 200 day simple moving average is $12.08. The stock has a market cap of $590.59 million, a price-to-earnings ratio of 63.70 and a beta of 0.91. Phreesia has a 12-month low of $7.77 and a 12-month high of $32.76. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. The business had revenue of $130.94 million for the quarter, compared to analysts’ expectations of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business earned ($0.07) earnings per share. As a group, research analysts anticipate that Phreesia will post 0.35 earnings per share for the current year.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.